Table 2 Correlation statistics of miR-27a with disease symptoms and markers.
From: MiR-27a as a diagnostic biomarker and potential therapeutic target in systemic sclerosis
miR-27a vs. DLCO | miR-27a vs. FVC | miR-27a vs. mRSS | miR-27a vs. ANA | miR-27a vs. Anti- dsDNA | miR-27a vs. TPO | miR-27a vs. anticcp | miR-27a vs. rf | miR-27a vs. crp | |
|---|---|---|---|---|---|---|---|---|---|
Pearson r | |||||||||
r | 0.000933 | 0.06084 | − 0.08529 | 0.04795 | − 0.03619 | 0.9202 | − 0.01608 | 0.134 | − 0.1279 |
95% confidence interval | − 0.2669 to 0.2686 | − 0.2103 to 0.3233 | − 0.3476 to 0.1894 | − 0.2851 to 0.3706 | − 0.5080 to 0.4523 | 0.6908 to 0.9813 | − 0.2826 to 0.2528 | − 0.1387 to 0.3879 | − 0.3826 to 0.1448 |
R squared | 8.71E−07 | 0.003702 | 0.007274 | 0.002299 | 0.00131 | 0.8467 | 0.000259 | 0.01796 | 0.01636 |
P value | |||||||||
P (two-tailed) | 0.9947 | 0.6621 | 0.5437 | 0.7813 | 0.8903 | 0.0002 | 0.9081 | 0.3339 | 0.3566 |
P value summary | ns | ns | ns | ns | ns | *** | ns | ns | ns |
Significant? (alpha = 0.05) | No | No | No | No | No | Yes | No | No | No |
